9 reports

  • Telix Pharma Enters into Licensing Agreement with Wilex

ONE UNIT IS DEFINED AS ONE SYSTEM.

  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Siemens AG
  • Terumo Corporation
  • WILEX AG
  • Telix Pharma Enters into Licensing Agreement with Wilex

OF THOSE WHO EXPERIENCE BIOCHEMICAL RECURRENCE, APPROXIMATELY ONE-THIRD DEVELOP METASTATIC PROSTATE CANCER.

  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Siemens AG
  • Stryker Corporation
  • WILEX AG
  • Telix Pharma Enters into Licensing Agreement with Wilex

BIOCHEMICALLY RECURRENT PROSTATE CANCER OCCURS IN UP TO ONE THIRD OF MEN WHO HAVE BEEN TREATED FOR PROSTATE CANCER, AND IS THEREFORE A VERY IMPORTANT MEDICAL CHALLENGE, " SAID JUDD MOUL, M. D., PROFESSOR OF SURGERY, UROLOGY, AT DUKE UNIVERSITY.

  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Siemens AG
  • Terumo Corporation
  • WILEX AG
  • Telix Pharma Enters into Licensing Agreement with Wilex

PET/ MRI IS PRIMARILY USED IN FUNCTIONAL ASSESSMENT OF CANCER, ESPECIALLY CANCERS OF HEAD, NECK, BRAIN AND PROSTATE.

  • Bruker Corporation
  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Siemens AG
  • WILEX AG
  • TELIX PHARMA ENTERS INTO LICENSING AGREEMENT WITH WILEX

(EARLY DETECTION OF CERVICAL CANCER).

  • GE Healthcare Limited
  • Hitachi, Ltd.
  • Konica Minolta Group
  • Medtronic, Inc.
  • WILEX AG
  • Telix Pharma Enters into Licensing Agreement with Wilex

PET/ MRI IS PRIMARILY USED IN FUNCTIONAL ASSESSMENT OF CANCER, ESPECIALLY CANCERS OF HEAD, NECK, BRAIN AND PROSTATE.

  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Siemens AG
  • Terumo Corporation
  • WILEX AG
  • Telix Pharma Enters into Licensing Agreement with Wilex

PET/ MRI IS PRIMARILY USED IN FUNCTIONAL ASSESSMENT OF CANCER, ESPECIALLY CANCERS OF HEAD, NECK, BRAIN AND PROSTATE.

  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Siemens AG
  • Terumo Corporation
  • WILEX AG
  • Telix Pharma Enters into Licensing Agreement with Wilex

PET/ MRI IS PRIMARILY USED IN FUNCTIONAL ASSESSMENT OF CANCER, ESPECIALLY CANCERS OF HEAD, NECK, BRAIN AND PROSTATE.

  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Siemens AG
  • Terumo Corporation
  • WILEX AG
  • Target
  • MERGERS AND ACQUISITIONS - DEAL REPORTS

Partner ## RedHill Biopharma, Ltd.

  • Pharmaceutical
  • Germany
  • Corporate Finance
  • M&A
  • WILEX AG